Teva's bid to block generic copaxone rejected
PATENT EXPIRY DATES 1/3 | New Drug Approvals
Does Drug Patent Evergreening Prevent Generic Entry? – DrugPatentWatch - Make Better Decisions
Teva Pharmaceuticals - Wikipedia
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Day 181 Generic Drug Launch - A Fast and Cheap Way to Find Generic Entry Opportunities – DrugPatentWatch - Make Better Decisions
Patent expiry dates for biologicals: 2016 update - GaBI Journal
Drug Patent Expirations and the “Patent Cliff”
The top 15 blockbuster patent expirations coming this decade | FiercePharma
Drug Patent expiry in 2017 – All About Drugs
Patent expiry dates for biologicals: 2016 update - GaBI Journal
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Time for a Turnaround at Teva Pharmaceuticals Industries Ltd? | The Motley Fool
Patent Loss in Pharma | Tefen Blog
India's drug industry to touch $48 billion by 2018
Celgene Settles U.S. Patent Litigation for Revlimid | Fortune
One, two, three, gone: Teva loses third patent on new Copaxone formula | FiercePharma
Legitimate patent extension or patent system abuse? | Pharmaceutical Patent Analyst
Court refuses injunctions in pharma patent case
Teva generics revenue by region 2016-2020 | Statista
Important Drug Patents to Expire in 2014 for Generic Production - Signicent LLP
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Top 5 expired blockbuster drugs - Clinical Trials Arena
Patent Docs: Top Drugs Losing Patent Exclusivity in 2021
Generic drug - Wikipedia
Monthly price reduction of generic drugs after patent loss U.S. 2015 | Statista
